Athens Medical Group (AMG), including Athens Medical Center, joins Clinerion’s hospitals network, and expands Clinerion’s footprint in Western Europe. Their Medsana Bucharest Medical Center in Romania will also join Clinerion’s Patient Network Explorer platform.
Athens Medical Group (AMG) runs eight ultramodern hospitals in Greece, seven in the Athens Metropolitan Area and one in Thessaloniki, Northern Greece. AMG cooperates with an extensive nationwide network of 390 diagnostic centers, eight haemodialysis units and a growing network of official associate centers throughout Greece. A multinational company, it operates Medsana clinics, four modern and specialized diagnostic centers in Romania, which also have presence, through affiliate companies, in North Africa, the Balkan area, Russia and the Former Soviet Union countries.
Joining Clinerion’s Patient Network Explorer platform will bring more innovative treatments to the patients of Athens Medical Center’s hospitals and clinics, and give their physicians more options in treating their patients. The group will also gain more exposure to global clinical trials run by international pharmaceutical companies and contract research organizations.
Drug developers working on innovative treatments will now benefit from access to new geographies and clinics with strong therapeutic focus.
Dr. Vassili G. Apostolopoulos, CEO of Athens Medical Group, commented: “A key aspect of our strategic planning is to constantly contribute to healthcare scientific and technological progress, always in favor of the patient.”
“This is a great partnership for Clinerion and we are happy to gain the great support of the entire Athens Medical Group!” says Ian Rentsch, CEO of Clinerion. “The level of ability and expertise brought by the physicians of Athens Medical Group will be a great benefit to clinical researchers using Clinerion’s Patient Network Explorer to support clinical research.”
About Clinerion
Clinerion website: www.clinerion.com
Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
For more information, please contact:
Le Vin Chin
Director, Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, 4053 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com
About Athens Medical Group:
Athens Medical Group website: www.athensmedicalgroup.com/
Athens Medical Center website: www.iatriko.gr/en/athens-medical-center
For more information, please contact:
Savvas Karagiannis
Communications Manager, Business Development Division
58 Kifissias Avenue, 151 25, Marousi, Athens, Greece
Tel. +30 210 6862521
s.karagiannis@iatriko.gr
Key Phase 3 Trial Results Lead to FDA Approval of Fabhalta for Paroxysmal Nocturnal Hemoglobinuria
December 6th 2023Clinical trials demonstrated superiority of Fabhalta to anti-C5s in hemoglobin improvement in the absence of transfusions and transfusion avoidance rate, showing clinically meaningful hemoglobin-level increases without the need for blood transfusions in patients with paroxysmal nocturnal hemoglobinuria.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.